Literature DB >> 15044100

Human MCRS2, a cell-cycle-dependent protein, associates with LPTS/PinX1 and reduces the telomere length.

Hai Song1, Yiliang Li, Guoyuan Chen, Zhen Xing, Jing Zhao, Kazunari K Yokoyama, Tsaiping Li, Mujun Zhao.   

Abstract

Human LPTS/PinX1 is a telomerase-inhibitory protein, which binds to the telomere protein Pin2/TRF1 and the catalytic subunit hTERT of telomerase. To explore the proteins that might be involved in the telomerase pathway, we performed a yeast two-hybrid screening with LPTS/PinX1 as the bait. A novel gene, MCRS2, encoding for an isoform of MCRS1/p78 and MSP58 was isolated. The expression of MCRS2 protein is cell-cycle dependent, accumulating in the very early S phase. MCRS2 interacts with LPTS/PinX1 in vitro, in vivo and colocalizes with LPTS/PinX1 in cells. MCRS2 and its amino terminus inhibit telomerase activity in vitro and long-term overexpression of MCRS2 in SMMC-7721 cells results in a gradual and progressive shortening of telomeres. Our findings suggest that MCRS2 might be a linker between telomere maintenance and cell-cycle regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044100     DOI: 10.1016/j.bbrc.2004.02.166

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Increased expression of the 58-kD microspherule protein (MSP58) is correlated with poor prognosis in glioma patients.

Authors:  Wei Lin; Xiao-Ming Li; Jing Zhang; Yi Huang; Jiang Wang; Jian Zhang; Xiao-Fan Jiang; Zhou Fei
Journal:  Med Oncol       Date:  2013-08-31       Impact factor: 3.064

2.  Mapping signals that are important for nuclear and nucleolar localization in MCRS2.

Authors:  Chung-Wen Kuo; Wen-Hung Wang; Shih-Tung Liu
Journal:  Mol Cells       Date:  2011-04-20       Impact factor: 5.034

3.  Cellular transformation by the MSP58 oncogene is inhibited by its physical interaction with the PTEN tumor suppressor.

Authors:  Koichi Okumura; Mujun Zhao; Ronald A Depinho; Frank B Furnari; Webster K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-19       Impact factor: 11.205

4.  A new cap for kinetochore fibre minus ends.

Authors:  Sabine Petry; Ronald D Vale
Journal:  Nat Cell Biol       Date:  2011-11-13       Impact factor: 28.824

5.  Expression of MSP58 in human colorectal cancer and its correlation with prognosis.

Authors:  Hai Shi; Shu-Jun Li; Bo Zhang; He-Liang Liu; Chang-Sheng Chen
Journal:  Med Oncol       Date:  2012-07-08       Impact factor: 3.064

6.  The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.

Authors:  Minxia Liu; Kecheng Zhou; Yunchao Huang; Yi Cao
Journal:  J Exp Clin Cancer Res       Date:  2015-10-14

7.  58-kDa microspherule protein (MSP58) is novel Brahma-related gene 1 (BRG1)-associated protein that modulates p53/p21 senescence pathway.

Authors:  Che-Chia Hsu; Yi-Chao Lee; Shiu-Hwa Yeh; Chang-Han Chen; Chih-Ching Wu; Tsui-Ying Wang; Yu-Nong Chen; Liang-Yi Hung; Yao-Wen Liu; Han-Ku Chen; Yi-Ting Hsiao; Wei-Sheng Wang; Jen-Hui Tsou; Yi-Huan Tsou; Mei-Hsiang Wu; Wen-Chang Chang; Ding-Yen Lin
Journal:  J Biol Chem       Date:  2012-05-04       Impact factor: 5.157

8.  MCRS2 represses the transactivation activities of Nrf1.

Authors:  Jia-Long Wu; Young-Sun Lin; Chi-Chiang Yang; Yu-Jen Lin; Shan-Fu Wu; Ying-Ting Lin; Chien-Fu Huang
Journal:  BMC Cell Biol       Date:  2009-02-02       Impact factor: 4.241

9.  MCRS1 associates with cytoplasmic dynein and mediates pericentrosomal material recruitment.

Authors:  Si-Hyung Lee; Mi-Sun Lee; Tae-Ik Choi; Hyowon Hong; Jun-Young Seo; Cheol-Hee Kim; Joon Kim
Journal:  Sci Rep       Date:  2016-06-06       Impact factor: 4.379

10.  Expression of MCRS1 and MCRS2 and their correlation with serum carcinoembryonic antigen in colorectal cancer.

Authors:  Chenguang Li; Mingxiao Chen; Pingwei Zhao; Desalegn Admassu Ayana; Lei Wang; Yanfang Jiang
Journal:  Exp Ther Med       Date:  2016-06-03       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.